Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Trial Identifier: D8850C00019
Sponsor: AstraZeneca
NCTID:: NCT05687877
Start Date: January 2023
Primary Completion Date: March 2026
Study Completion Date: March 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Chiba, Japan
Japan Fukuoka, Japan
Japan Fukushima, Japan
Japan Gifu, Japan
Japan Hiroshima, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Ishikawa, Japan
Japan Iwate, Japan
Japan Kagoshima, Japan
Japan Kanagawa, Japan
Japan Kumamoto, Japan
Japan Kyoto, Japan
Japan Mie, Japan
Japan Nagasaki, Japan
Japan Nara, Japan
Japan Niigata, Japan
Japan Oita, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Tokyo, Japan
Japan Tottori, Japan
Japan Yamanashi, Japan